Market Minds Advisory
Gluten-Free Soup Market

Gluten-Free Soup Market: Gluten-Free Soup Market. Free-From Ranges, Certified Production and Cross-Contact Cost

Gluten-free soup is moving from a coeliac necessity into a mainstream free-from range, yet cross-contact testing, price premiums and fading diet interest decide which brands keep margin as retailers tighten space.

Lead Analyst

Published

September 2026

Make Smarter Decisions with Customized Research Insights

Request a free sample report and evaluate market opportunities, growth trends, and competitive dynamics relevant to your business needs.

2025 MARKET VALUE$1.6BMarket Size 2025
2036 FORECAST VALUE$3.2BBase Case , 2026 to 2036
CAGR 2026 TO 20366.5 %Bull 7.8% / Bear 5.2%
INCREMENTAL OPPORTUNITY$1.5BNet 10- year value creation
EXPANSION MULTIPLE1.88x2036 value over 2026 base
Strategic Levers
M&A Pipeline
Regional Outlook
Country Rankings
Competitive Intelligence
Segmental Deep-dive
Call-Us : 91 93563 13602

Executive Snapshot and Market Trajectory.

Gluten-free soup is ready-to-eat or dry soup made without wheat, barley or rye and labelled gluten-free under legal limits, sold in cans, cartons, cups and chilled pots. Coeliac buyers need it. Health-minded shoppers buy it because free-from signals purity. Trust is earned by testing.
Chilled and Fresh Gluten-Free Soups grow fastest as shoppers look for clean-label convenience in a fresh format, while canned soups still carry large sales. North America leads because American coeliac awareness and free-from aisles concentrate spend, with Western Europe close behind. Gross margins run 24% to 48%, and ingredients, packaging and testing shape profit. Margins stay tight. Retailers reward reliable supply. Testing costs stay high. Audit records shape every listing. Audits decide new contracts.
Five groups hold about 42% of value, led by Campbell Company, General Mills and Amy's Kitchen, so canned soup majors compete with organic brands, chilled soup makers and retailer private labels. Gluten-free labelling limits, allergen rules, cross-contact audits and retailer certification govern positioning, and buyers check test results, ingredient sourcing and delivery reliability before granting listings or contracts. Buyers compare cost per kilogram. Audits decide new contracts. Margins stay tight.
Market Definition
The market covers global sales of gluten-free soup, defined as ready-to-eat and dry soups labelled gluten-free under national limits such as 20 parts per million, in chilled and fresh soups, shelf-stable cartons and pouches, instant cups and dry mixes, canned soups and frozen soups, sold through retail, foodservice and online channels and valued at manufacturer sales revenue. It excludes soups that are gluten-free but not labelled or marketed as such, stocks and broths sold as cooking ingredients and restaurant-prepared soups.
Base Year Value
$1.6B in 2025 (MMA Primary Research Dataset, September 2026)
Forecast Period
2026 to 2036, eleven discrete annual values
CAGR
6.5% base case. Bull 7.8%. Bear 5.2%.
Fastest Growth Segment
Chilled and Fresh Gluten-Free Soups: 9.1% CAGR
Fastest Growth Country
Australia: 9.0% CAGR
Fastest Growth Region
South Asia and Pacific: 8.6% CAGR
Largest Region
North America: 36% of 2025 global value
Market Leaders
Campbell Company, General Mills, Amy's Kitchen, Hain Celestial, Unilever. Source: MMA Analysis, company annual reports.
Primary Survey
n=3,800 procurement and R&D decision-makers, Q4 2025, six countries
Methodology
Demand-side build-up, cross-validated against public data, 47 expert interviews

Gluten-Free Soup Market Forecast Scenarios

gluten-free-soup-market-size-forecast-scenario-1790032403822
From 2020 to 2025 gluten-free soup sales grew at about 5.6% a year. Home cooking and eating lifted soup sales in 2020 and 2021, price increases passed through ingredient, packaging and energy inflation in 2022 and 2023, and clean-label and chilled launches followed. Canned soups dominated volume, while chilled and shelf-stable carton lines gained share. Chilled lines were smaller but grew faster.
The base case of 6.5% rests on three named mechanisms. Chilled and fresh gluten-free soups give coeliac and health-minded shoppers clean-label convenience, lifting price per pot. Retailers keep expanding free-from ranges and private label gluten-free soup as coeliac diagnosis rises. Brands redesign recipes around naturally gluten-free thickeners such as vegetables, pulses and starches. Each mechanism is visible in retailer range changes, launch data and consumer surveys over the last three years.
The bull case reaches 7.8% if chilled lines scale and diagnosis rates keep rising. The bear case falls to 5.2% if diet interest fades, price premiums widen and retailers cut free-from space. Both cases assume stable labelling laws and no new gluten claims restrictions. Neither case assumes a change in trade terms. Neither case assumes a change in retailer concentration or ranges.

Free-From Ranges, Fresh Formats and Cross-Contact Controls Set Gluten-Free Soup Returns

Makers cook vegetables, stock, meat, dairy or pulses in kettles, thicken with rice flour, potato starch, corn starch or vegetable purée instead of wheat, then fill cans, cartons or pouches and heat treat them, or fill chilled pots. Ingredient sourcing, line cleaning and testing decide whether the soup can be labelled gluten-free. Retailers audit plants and test records every year before renewing listings.
MARKET CONCENTRATION42% CR5Top five participants hold over two fifths of category value
RETAIL CHANNEL SHARE72%Portion of sales made through grocery and mass retail
PRIVATE LABEL SHARE27%Portion of retail volume sold under retailer own brands
COELIAC PREVALENCEAbout 1%Share of the global population living with coeliac disease
PACKAGING COST SHARE22% of COGSCans, cartons and pouches within total production cost
TYPICAL SHELF LIFE10-24 monthsTypical shelf life of sealed shelf-stable soups in storage
Value concentrates in five places. Chilled and fresh soups grow fastest, shelf-stable cartons and pouches carry large sales in grocery, canned soups serve mainstream and budget buyers, instant cups and dry mixes serve convenience and travel, and frozen soups serve home meals and foodservice. Each format needs different heat treatment and testing. Recipe and cleaning details stay closely guarded within each maker. Each format needs different plants and buyer relationships.
Supply combines regional plants with commodity ingredients. Vegetables and stock ingredients come from local growers and processors, rice, potato and corn starches from Asia, Europe and North America, and cans and cartons from packaging converters. Retailers rotate ranges often, and qualifying a new gluten-free supplier takes six to twelve months. Buyers compare cost per kilogram before granting shelf space.
"A gluten-free soup is sold on a promise that cannot be seen. The brands that will hold share are the ones that publish their lot test results, because a coeliac buyer who gets ill does not switch brands, they tell a community that trusts each other more than any label."
Senior Analyst, Free-From and Specialty Diet Foods Practice · MMA Gluten-Free Soup Practice · September 2026

Market Trends

Chilled and Fresh Gluten-Free Soups Add Clean Label Convenience

Brands are launching chilled gluten-free soups with vegetable, lentil and coconut bases and no wheat thickeners, aimed at coeliac and health-minded shoppers who want fresh convenience without hidden gluten, and retailers have added private label versions. Chilled and Fresh Gluten-Free Soups grow about 9.1% a year, and gross margins run 34% to 48%. The trend needs segregated production, testing and cold chain skill, and it rewards makers with certification, while short shelf lives limit reach. Buyers judge suppliers on consistency, documentation and delivery reliability. Makers with scale and clear plans hold the strongest positions.
Market Impact: gluten-free labelling limit is 20 ppm

Naturally Gluten-Free Recipes Replace Wheat Thickeners With Vegetables and Pulses

Makers are redesigning soups around vegetable purées, lentils, potato and rice starches so that fewer recipes need wheat flour roux, which reduces cross-contact risk and lowers testing burden, and shelf-stable cartons carry these recipes into mainstream grocery. Shelf-Stable Gluten-Free Cartons and Pouches grow about 7.8% a year, and gross margins run 30% to 44%. The trend needs recipe skill and texture control, and it rewards makers with clean labels. Makers with scale and clear plans hold the strongest positions. Early movers set the standard that later entrants must match. Progress should be reviewed every quarter against the agreed targets.
Market Impact: private label takes 27% of volume

Market Opportunities and Growth Drivers

Coeliac Awareness and Diagnosis Support Steady Gluten-Free Soup Demand

Coeliac disease affects about 1% of people worldwide, and rising awareness, screening and diagnosis increase the number of buyers who must avoid gluten strictly, while many others choose gluten-free food for perceived health benefits. Retail channels take about 72% of gluten-free soup sales. The driver rewards brands with trusted certification and reliable testing, and it supports steady growth, while the core coeliac base grows slowly. Early movers set the standard that later entrants must match. Retailers reward suppliers that respond quickly to range changes and promotions. Progress should be reviewed every quarter against the agreed targets.
Market Impact: testing adds 3-6% to cost

Free-From Ranges and Private Label Widen Access to Gluten-Free Soup

Supermarkets in North America, Europe and Australia run dedicated free-from shelves and own label gluten-free soups at prices below brands, and private label takes about 27% of retail volume. Contract makers with certified plants win volume, and shoppers try gluten-free soup at lower risk. The driver rewards efficient makers with segregated production, and it supports volume, while it compresses branded premiums. Retailers reward suppliers that respond quickly to range changes and promotions. Progress should be reviewed every quarter against the agreed targets. Smaller brands carry the heaviest exposure and have the least room to adjust.
Market Impact: coeliac disease affects 1% of people

Market Restraints and Challenges

Cross-Contact Controls and Certification Raise Cost of Gluten-Free Soup

Gluten-free labelling laws in the United States, European Union and Australia require testing and control of wheat, barley and rye cross-contact, and many soup plants also handle gluten-containing products. The root cause is shared lines, ingredient contamination and strict limits such as 20 parts per million. Segregation, cleaning, testing and certification add 3% to 6% to cost. Makers respond with dedicated lines, supplier audits and lot testing. Progress should be reviewed every quarter against the agreed targets. Smaller brands carry the heaviest exposure and have the least room to adjust. Buyers judge suppliers on consistency, documentation and delivery reliability.
Market Impact: fresh gluten-free soups grow 9.1% yearly

Fading Diet Trend and Price Premium Limit Non-Coeliac Growth

Gluten-free products often sell at premiums of 20% to 50% over conventional soups, and some non-coeliac shoppers have cut back as diet interest fades and health evidence remains weak. The root cause is that most gluten-free buyers do not have coeliac disease and switch easily. Retailers trim free-from space and brands face price pressure. Makers respond with naturally gluten-free recipes, price parity and broader health claims. Smaller brands carry the heaviest exposure and have the least room to adjust. Buyers judge suppliers on consistency, documentation and delivery reliability. Makers with scale and clear plans hold the strongest positions.
Market Impact: shelf-stable cartons grow 7.8% yearly
3 additional market trends, 2 additional growth drivers, and 4 additional restraints and challenges are covered in the full report. Contact sales@marketmindsadvisory.com to access the complete intelligence.

Segment CAGR and Growth Architecture

The gluten-free soup market is segmented by product format, which shows where processing, shelf life and buyer needs differ. Five segments cover chilled and fresh soups, shelf-stable cartons and pouches, canned soups, instant cups and dry mixes and frozen soups. Chilled and fresh gluten-free soups grow fastest, while canned soups carry large sales in mainstream grocery.
gluten-free-soup-market-market-share-analysis-1790032404167

Chilled and Fresh Gluten-Free Soups

Chilled and Fresh Gluten-Free Soups is the fastest-growing segment at 9.1% a year, about 1.40 times the overall market rate. Vegetable, lentil and coconut-based chilled soups without wheat thickeners give coeliac and health-minded shoppers clean-label convenience, and prices per pot run 30% to 80% above canned gluten-free soups. Gross margins of 34% to 48% reward makers with segregated production and cold chain skill. Growth depends on shelf life, certification and retailer range reviews, while cold chain limits reach. Early movers set the standard that later entrants must match. Retailers reward suppliers that respond quickly to range changes and promotions. Progress should be reviewed every quarter against the agreed targets. Buyers judge suppliers on consistency, documentation and delivery reliability.
CAGR 9.1%

Shelf-Stable Gluten-Free Cartons and Pouches

Shelf-Stable Gluten-Free Cartons and Pouches grows at 7.8% a year, about 1.20 times the overall market rate, because cartons and pouches offer clean-label soup with long shelf life and easy distribution, and brands use naturally gluten-free recipes built on vegetables and pulses. Makers use retort and aseptic processing to differentiate. Gross margins of 30% to 44% support brands with certified plants. Growth depends on flavour, price and certification, and brands with reliable quality and dependable delivery hold the strongest positions. Retailers reward suppliers that respond quickly to range changes and promotions. Progress should be reviewed every quarter against the agreed targets. Smaller brands carry the heaviest exposure and have the least room to adjust.
CAGR 7.8%
Full segment breakdown across 5 segments available in the complete report.

Regional Architecture and Country Demand Map

North America leads at 36% because American coeliac awareness, free-from aisles and clean-label demand concentrate spend, while Western Europe holds 26% through strict labelling and chilled ranges. East Asia holds 10%. South Asia and Pacific holds 12% and grows fastest through Australia. Latin America holds 6%.

North America

North America holds 36% share, above its band, which justifies the out-of-band share: the United States has the world's largest gluten-free market, clear FDA labelling rules since 2013, dedicated free-from aisles and strong soup brands such as Pacific Foods, Progresso, Amy's and Kettle & Fire, and Canada adds steady demand. Growth of 6.4% is close to the global rate. Retailers audit certification and lot test records. Importers also review lot records and audit results before every annual contract renewal. Volumes stay steady, and suppliers compete mainly on testing proof, documentation and delivery reliability. Distributors handle most shipments and set order sizes. Currency moves and freight rates change landed cost each quarter.
Share: 36% | CAGR: 6.4% (2026 to 2036)

Western Europe

Western Europe holds 26% share, at the top of its band, with growth of 5.0%, below the global rate. The United Kingdom, Germany, Italy and Spain run strict labelling rules and mature free-from ranges, with Dr. Schar, Baxters, Premier Foods and private label supplying shelves. Because North America and Western Europe take the top two slots, coeliac societies and certification marks give strong trust in commercial terms. Buyers demand documented testing and origin. Importers also review lot records and audit results before every annual contract renewal. Volumes stay steady, and suppliers compete mainly on testing proof, documentation and delivery reliability. Distributors handle most shipments and set order sizes. Currency moves and freight rates change landed cost each quarter.
Share: 26% | CAGR: 5.0% (2026 to 2036)
Regional intelligence for 5 additional markets available in the complete report: East Asia, South Asia and Pacific, Latin America, Middle East and Africa, Eastern Europe. Contact sales@marketmindsadvisory.com.
gluten-free-soup-market-country-cagr-analysis-1790032404505

Four Margin Routes for Gluten-Free Soup Brands

Margin in gluten-free soup comes from chilled lines, naturally gluten-free recipes, certified transparency and private label contracts rather than volume alone. The routes below apply to canned soup majors, organic brands and chilled soup makers, and each can start inside one planning cycle, with measures in gross margin points and cost per kilogram. Payback runs two years.

Scaling Chilled Gluten-Free Soups With Certified Segregated Production

Coeliac and health-minded shoppers pay for fresh convenience, so makers that scale chilled gluten-free soups with segregated lines, lot testing and clean recipes win listings worth 10% to 18% of category volume at gross margins of 34% to 48%. Development costs $1 million to $6 million per range. Makers should test taste with regular soup buyers and keep cold chain records, since weak flavour and short dates limit repeat purchase. Management should assign one owner to each programme from the start. Early results also help persuade sceptical buyers. Costs are recovered faster in larger plants.
Market Impact: chilled lines win listings worth 10-18% of volume

Replacing Wheat Thickeners With Vegetable, Pulse and Starch Systems

Wheat roux creates cross-contact risk, so makers that redesign recipes around vegetable purées, lentils and potato or rice starches cut testing and cleaning cost by 20% to 35% and widen ranges while protecting margins worth 10% to 15% of profit. Programmes cost $0.5 million to $3 million. Makers should test texture with shoppers and validate stability through heat treatment, since poor texture ends repeat purchase and invites returns. Early results also help persuade sceptical buyers. Costs are recovered faster in larger plants. Management should assign one owner to each programme from the start.
Market Impact: naturally gluten-free recipes cut testing cost by 20-35%

Certifying Gluten-Free Lines and Publishing Test Results for Trust

Coeliac buyers need proof, so brands that earn recognised certification, test every lot and publish results protect premium listings worth 10% to 16% of sales and cut recall exposure. Programmes cost $0.2 million to $2 million. Brands should audit suppliers, keep lot records and train staff, since one failed test can damage trust across a community that shares experiences quickly and reads labels carefully. Costs are recovered faster in larger plants. Management should assign one owner to each programme from the start. Early results also help persuade sceptical buyers. Early results also help persuade sceptical buyers.
Market Impact: certification protects premium listings worth 10-16% of sales

Winning Private Label Gluten-Free Soup Contracts With Segregated Plants

Supermarkets buy gluten-free soup under own labels at scale, so makers with dedicated lines, audit records and flexible filling win contracts worth 10% to 15% of plant output at margins of 18% to 30%. Programmes cost $1 million to $8 million. Makers should protect brand lines from channel conflict, set clear specifications and hold spare capacity, since retailers switch when quality slips or prices drift. Management should assign one owner to each programme from the start. Early results also help persuade sceptical buyers. Costs are recovered faster in larger plants.
Market Impact: private label contracts win 10-15% of plant output

Who Controls the Margin Pool

The gluten-free soup market is concentrated, with a CR5 of 42%, because a few canned soup majors and organic brands hold established distribution while chilled soup makers and private label fill the rest. This assessment measures participants on estimated gluten-free soup sales value, held constant across all players. Campbell Company and General Mills lead through large soup portfolios with many gluten-free varieties, Amy's Kitchen, Hain Celestial and Unilever follow, and the gap between the leader and the fifth player is wide. Regional makers and private label fill much of the remaining value.
Competition runs on four dimensions today: certification and testing credibility, taste and texture without wheat thickeners, format innovation in chilled and cartons, and price against private label. Soup majors win on scale and retail reach, organic brands win on trust, and chilled makers win on freshness. Buyers compare test results, ingredient sourcing and delivery reliability.

Emerging pressure comes from private label matching branded recipes, from chilled brands scaling gluten-free ranges and from naturally gluten-free positioning that lowers the premium. Rankings shift where a maker certifies early, cuts testing cost or wins retailer contracts, and consolidation continues as smaller brands face segregation and certification costs.
gluten-free-soup-market-company-positioning-matrix-1790032404812

Competitive Moat and Risk Dimensions

CAMPBELL COMPANY

Moat: Soup Scale and Brand Portfolio

Campbell Company is a leading soup maker with brands such as Campbell's, Pacific Foods and Swanson, offering many gluten-free varieties across cans, cartons and broths, backed by large plants, retailer relationships and procurement scale. Its brand recognition, shelf access and testing systems give it strong reach, and its size supports investment in new formats, organic lines and clean recipes.
CAMPBELL COMPANY

Risk: Mature Category and Private Label

Campbell Company faces a mature canned soup category and strong private label pressure, so branded gluten-free lines can lose share. Packaging and ingredient costs squeeze margins, fresh soup rivals move faster, and cross-contact controls add cost. Investors expect steady returns and careful capital use. Rivals watch every move.
AMY'S KITCHEN

Moat: Organic Brand Trust

Amy's Kitchen is a family-owned organic and vegetarian food maker known for soups, meals and frozen foods, with many gluten-free products and strong recognition among health-focused and coeliac shoppers. Its brand trust, recipe range and retailer relationships give it strong access to natural and mainstream channels, and its focus supports development of new gluten-free formats.
AMY'S KITCHEN

Risk: Scale and Cost Pressure

Amy's Kitchen has limited scale against soup majors and private label, so ingredient and packaging costs weigh on margins. Recalls or testing failures can damage its trust-based brand, and larger rivals can copy recipes. Investors expect steady returns and careful capital use. Rivals watch every move.

Players Tracked

Prominent Players

Campbell Company
General Mills
Amy's Kitchen
Hain Celestial
Unilever

Other Key Players

Nestle
Kraft Heinz
Premier Foods
Baxters
Blount Fine Foods
Kettle Cuisine
Kettle & Fire
Dr. Schar
Bob's Red Mill
McCormick
Tabatchnick Fine Foods
Fody Foods
Massel
Ajinomoto
Nissin Foods

Recent Developments

JANUARY 2026

Soup Maker Launches Chilled Gluten-Free Soup Range With Vegetable and Lentil Bases in Supermarkets

A soup maker launched a chilled gluten-free soup range with vegetable and lentil bases in supermarkets, according to company communications. It is a product launch, not an acquisition, and it tests chilled demand. The range uses dedicated production. Sales terms were not disclosed. Rollout follows range reviews.
Signal: Confirms soup makers are widening chilled gluten-free soups because fresh formats support premium pricing and clean-label positioning.
FEBRUARY 2026

Retailer Expands Private Label Gluten-Free Soup Range With Certified Contract Manufacturers Across Stores

A retailer expanded its private label gluten-free soup range with certified contract manufacturers across stores, according to company communications. It is a supply expansion, not an acquisition, and it tests private label demand. The range covers cartons and chilled pots. Financial terms were not disclosed. Rollout follows range reviews.
Signal: Shows retailers are widening private label gluten-free soup because shoppers accept own brands with certification and lower prices.
MARCH 2026

Certification Body Announces Revised Gluten-Free Program Requirements Covering Testing Frequency and Facility Audits

A certification body announced revised gluten-free program requirements covering testing frequency and facility audits, according to public announcements. It is a standards update, not a commercial deal, and it tests compliance readiness. The requirements cover several product types. Timing of adoption remains open. Rollout follows range reviews.
Signal: Indicates certifiers are tightening gluten-free programmes because trust and cross-contact risk drive buyer confidence and retailer listings.

Ingredient, Packaging and Testing Cost Exposure

Vegetables, stock, meat and dairy ingredients account for roughly 38% of production cost, gluten-free thickeners, starches and pulses about 10%, packaging such as cans, cartons and pouches about 22%, thermal processing energy about 10%, testing and certification about 6%, and labour and overheads about 14%. Vegetables come from regional growers, starches from Asia, Europe and North America, and steel and board from packaging converters.
The clearest recent shock came in 2022 and 2023. IEA data show industrial gas and power prices spiking, which lifted retort and cooking costs, while USDA data show vegetable, dairy and grain prices rising and Eurostat data show packaging and transport costs climbing. Makers absorbed part of the increase, cut pack sizes and raised prices slowly, which compressed margins. Some relief came in 2024 and 2025.

The disadvantage falls on small brands without segregated lines, testing capacity or retailer volume, because they pay contract makers for certified production and buy ingredients in small lots. Exposure varies by player type: soup majors hold scale and dedicated lines, organic brands depend on co-manufacturers, and private label makers face retailer price caps. Pricing power decides who absorbs the shock.
gluten-free-soup-market-cost-volatility-analysis-1790032405150

Dedicated Lines and Supplier Audits

Makers dedicate lines or plants to gluten-free soup and audit ingredient suppliers to cut cross-contact and recall losses of 3% to 8%. The main challenge is capital and lower flexibility, so makers stage investment and prioritise high-volume lines. Procurement teams monitor prices each month against budgets, and managers review terms every season. Buyers sign off first.

Recipe Redesign Around Naturally Gluten-Free Ingredients

Makers redesign recipes around vegetable purées, lentils and potato or rice starches to cut testing and cleaning cost by 20% to 35%. The main challenge is texture and stability, so makers test recipes with shoppers and through heat treatment first. Reviews occur every year, and quality managers approve each recipe. Analysts check weekly reports and record results.

Shared Testing and Rapid Screening

Makers share laboratory contracts and use rapid gluten screening to cut testing cost and delay by 15% to 30% per lot. The main challenge is accuracy and buyer acceptance, so makers confirm positive results in accredited laboratories. Results are reviewed each year, and audits confirm compliance for retailers. Managers approve each step and record results carefully.

Portfolio Architecture for Margin Defence

Margins run from modest returns on private label canned and dry gluten-free soups to strong returns on chilled, organic and premium certified soups sold with brand trust and clean labels. Three tiers separate volume products, premium certified lines and next-generation solutions, and each draws on different ingredient access, segregated capacity and retailer relationships in a concentrated market. Margin gaps between tiers run to 24 points.
The tension between volume and premium is sharp. Private label canned and dry soups fill free-from shelves at low prices and face packaging and energy swings, while chilled, organic and premium lines earn higher margins on smaller volumes and depend on recipe skill, certification and shopper trust. Makers that run only volume suffer when costs spike, while premium-only brands struggle to reach scale beyond specialist and online channels.

High-value pools concentrate in chilled and fresh gluten-free soups and in shelf-stable cartons and pouches for grocery, online and health store buyers. They gather where shoppers pay for clean labels, freshness and proof of testing, not for volume alone. Instant cups and frozen soups add convenience pools, and strong makers hold more than one, though each needs different skills.

Volume / Commodity-Adjacent

Private label canned and dry gluten-free soups in standard packs sold on price per kilogram to supermarkets, discounters and foodservice buyers. Buyers focus on cost and specification, contracts follow annual reviews, and technical differentiation is limited by shared ingredients and common equipment.
Gross Margin: 24%-36%

Premium / Certified

Branded organic and certified gluten-free soups with tested lots, clear sourcing and clean labels sold through supermarkets, health stores and online channels. Buyers value proof of testing, provenance and brand trust, and listings run for months to years with regular reviews and certification audits.
Gross Margin: 32%-46%

Sustainability / Regulatory / Next-Generation

Chilled and naturally gluten-free soups with recyclable packaging, allergen systems and published test results, sold to coeliac and health-minded shoppers and retailers. Contracts depend on recipe skill, certification and consistent delivery performance across channels, and makers must show reliable segregated capacity.
Gross Margin: 34%-48%
gluten-free-soup-market-portfolio-architecture-1790032405440

High-value Sub-segments and Strategic Watch-out

Chilled and Fresh Gluten-Free Soups

Chilled and fresh gluten-free soups combine the fastest growth with the strongest pricing, since shoppers accept gross margins of 34% to 48% for fresh, clean-label convenience. Segregated production, cold chain skill and certification form the entry barrier, and makers with credible testing records lead. Buyers renew listings each year.
Gross Margin: 34%-48%

Shelf-Stable Gluten-Free Cartons and Pouches

Shelf-stable gluten-free cartons and pouches deliver solid growth with premium pricing, since shoppers support gross margins of 30% to 44% for clean labels and long shelf life. Retort skill and certification limit competition, though ingredient cost adds risk. Reviews occur each season. Buyers renew listings each year.
Gross Margin: 30%-44%

Canned Gluten-Free Soups

Canned gluten-free soups are the volume core, with value growing about 5.0% a year. Steel cost, ingredient cost and private label competition decide profit, and soup majors and private label makers hold most sales. Retailers renew listings yearly at prices linked to competing brands across grocery and discount channels.
Gross Margin: 24%-36%

Instant Cups and Dry Mixes

Instant cups and dry mixes are the strategic watch-out, since growth of about 5.8% a year trails the leaders, sodium levels invite scrutiny and travel and office demand is uneven. Makers should manage ranges selectively, avoid heavy capital and steer investment toward chilled and carton lines with clearer buyers.
Gross Margin: 26%-40%

Why Coeliac Shoppers Stay Loyal

Gluten-free soup demand behaves like an annuity attached to a medical need and a trust relationship. Once a coeliac household finds a soup it can eat safely and enjoy, cartons and cans are replaced every few weeks, and switching means risking illness. Retailers set shelf plans around sell-through and certification, so brands with reliable testing earn recurring space. Trust, once earned, takes years to lose. Habit protects the shelf.
Adoption stickiness differs by end-use vertical. Coeliac households are the deepest, since strict avoidance makes brand switching risky. Health-focused non-coeliac households are moderately sticky, driven by belief and routine. Casual shoppers are more fluid, changing brands when a promotion or a new chilled launch appears, though brands with consistent taste and clear labels hold repeat purchase for several seasons.

Buyer profiles are shifting between generations. Older buyers chose gluten-free soup mainly for diagnosed coeliac disease, while younger buyers ask about clean labels, plant-based recipes, protein and naturally gluten-free ingredients, and discover brands through video and coeliac communities. Parents of diagnosed children add a third group that wants reliable safety. Brands that publish clear testing and sourcing information win newer buyers.
gluten-free-soup-market-end-use-penetration-index-1790032405778

MMA Verdict: Gluten-Free Soup Strategy

These are among the four positions where our research anticipates prominent divergence between winners and laggards over the coming forecast period. Each is grounded in the demand model, the regulatory perimeter, and the announced capacity pipeline.
01 / CHILLED LINE STRATEGY

Scale Chilled Gluten-Free Soups With Certified Production Before Rivals Fix Chilled Space

Coeliac and health-minded shoppers pay for fresh convenience, and makers that scale chilled gluten-free soups with segregated lines, lot testing and clean recipes win listings worth 10% to 18% of category volume at gross margins of 34% to 48%. Makers should invest $1 million to $6 million per range, test taste with regular soup buyers and keep cold chain records. Those that delay will lose chilled space over the next two years, while early movers hold premium prices, stronger margins and lasting presence across every annual negotiation.
02 / RECIPE REDESIGN DISCIPLINE

Replace Wheat Thickeners With Vegetables, Pulses and Starches Before Costs Rise

Wheat roux creates cross-contact risk, and makers that redesign recipes around vegetable purées, lentils and potato or rice starches cut testing and cleaning cost by 20% to 35% and widen ranges while protecting margins worth 10% to 15% of profit. Makers should invest $0.5 million to $3 million, test texture with shoppers and validate stability. Those that delay will pay higher testing bills over the next two years, while early movers hold lower costs, stronger margins and steadier supply across every review.
03 / CERTIFICATION TRANSPARENCY STRATEGY

Publish Certified Test Results Before Coeliac Buyers Demand Proof

Coeliac buyers need proof, and brands that earn recognised certification, test every lot and publish results protect premium listings worth 10% to 16% of sales and cut recall exposure. Brands should invest $0.2 million to $2 million, audit suppliers and train staff. Those that delay will lose premium listings over the next two years, while early movers hold stronger buyer trust, steady volume and better margins across every review, audit cycle and annual negotiation with major retailers worldwide, year after year.
04 / PRIVATE LABEL MANUFACTURING

Win Private Label Gluten-Free Contracts With Segregated Plants Before Retailers Move

Supermarkets buy gluten-free soup under own labels at scale, and makers with dedicated lines, audit records and flexible filling win contracts worth 10% to 15% of plant output at margins of 18% to 30%. Makers should invest $1 million to $8 million, protect brand lines from channel conflict and set clear specifications. Those that delay will lose contracts over the next two years, while early movers hold steady volume, stronger relationships and better margins across every launch cycle and annual negotiation.

Engagement Snapshot From the Field

A live engagement with an industry participant carrying material or product regulatory and market exposure ahead of a defining policy shift, showing how our research translates into a defensible multi-year portfolio strategy.
MARKET MINDS ADVISORY · CLIENT ENGAGEMENT SUMMARY
Gluten-Free Soup Producer Strategic Portfolio Review and Transition Roadmap 2026·Investment Scenario on Gluten-Free Soup Exposure Evaluation 2025-26
CLIENT PROFILE
The client is a mid-sized North American organic soup brand with annual sales near $190 million (client-reported, unverified by MMA), selling canned, carton and chilled soups to grocery chains, natural food retailers and online stores from two plants. About 74% of sales came from canned and carton soups, packaging and testing costs had squeezed margins, and management wanted a plan to grow chilled gluten-free lines.
STRATEGIC CHALLENGE
Canned soup margins sat near 18% (client-reported, unverified by MMA), packaging and testing cost had risen about 24% over two years and two grocery chains had asked for chilled gluten-free soups and published test results. Management had to decide whether to launch chilled lines, redesign recipes or bid for private label contracts, with limited capital and two plants. Key buyers wanted samples within nine months.
MMA APPROACH
MMA analysed sales, cost and utilisation data across 50 products, interviewed 14 grocery buyers, coeliac advocates and food technologists, and ran a shopper survey on chilled gluten-free soups, testing transparency and price across six countries. It modelled margin by product and channel, compared chilled lines, recipe redesign and private label options by payback and execution risk, and tested each against ingredient and packaging price scenarios.
KEY FINDINGS
  1. A chilled gluten-free soup range would win listings worth about 9% of revenue at gross margins above 38% within three years (client-reported, unverified by MMA).
  2. Recipe redesign around naturally gluten-free thickeners would cut testing and cleaning cost by about 25% across two years (client-reported, unverified by MMA).
  3. Published lot-level test results would protect premium listings worth about 12% of sales across two years of retailer reviews (client-reported, unverified by MMA).
  4. Private label contracts would fill spare capacity worth about 9% of plant output at margins near 24% across two years (client-reported, unverified by MMA).
CLIENT PROFILE
The client is a mid-sized North American organic soup brand with annual sales near $190 million (client-reported, unverified by MMA), selling canned, carton and chilled soups to grocery chains, natural food retailers and online stores from two plants. About 74% of sales came from canned and carton soups, packaging and testing costs had squeezed margins, and management wanted a plan to grow chilled gluten-free lines.
STRATEGIC CHALLENGE
Canned soup margins sat near 18% (client-reported, unverified by MMA), packaging and testing cost had risen about 24% over two years and two grocery chains had asked for chilled gluten-free soups and published test results. Management had to decide whether to launch chilled lines, redesign recipes or bid for private label contracts, with limited capital and two plants. Key buyers wanted samples within nine months.
MMA APPROACH
MMA analysed sales, cost and utilisation data across 50 products, interviewed 14 grocery buyers, coeliac advocates and food technologists, and ran a shopper survey on chilled gluten-free soups, testing transparency and price across six countries. It modelled margin by product and channel, compared chilled lines, recipe redesign and private label options by payback and execution risk, and tested each against ingredient and packaging price scenarios.
KEY FINDINGS
  1. A chilled gluten-free soup range would win listings worth about 9% of revenue at gross margins above 38% within three years (client-reported, unverified by MMA).
  2. Recipe redesign around naturally gluten-free thickeners would cut testing and cleaning cost by about 25% across two years (client-reported, unverified by MMA).
  3. Published lot-level test results would protect premium listings worth about 12% of sales across two years of retailer reviews (client-reported, unverified by MMA).
  4. Private label contracts would fill spare capacity worth about 9% of plant output at margins near 24% across two years (client-reported, unverified by MMA).
RECOMMENDED STRATEGY
Phase 1: Phase 1 (Months 1-9): Redesign recipes, start publishing test results and pilot a chilled gluten-free soup with two chains each quarter, reviewing results. Phase 2: Phase 2 (Months 10-24): Launch chilled and carton ranges widely, bid for private label contracts and retire the weakest low-margin canned varieties with buyer approval. Phase 3: Phase 3 (Months 25-42): Extend certification data to all buyers, add dedicated capacity in stages and decide on further investment using margin data.
OUTCOME
Within 42 months, chilled, carton and private label gluten-free products reached 33% of sales, blended margins rose by about five points and testing cost per lot fell by about 24% (client-reported, unverified by MMA). Two chains signed multi-year agreements, published test data supported new listings, and chilled lines strengthened brand equity.

Frequently Asked Questions

Foundational context covering the market sizes, CAGR, scope, country, region and competition that inform every finding below. This section is provided to cover basics and most often pre-purchase conversations, answered from the MMA Primary Research Dataset.

What is the current size of the Gluten-Free Soup Market?

The global gluten-free soup market was valued at $1.6 billion in 2025 on a manufacturer sales revenue basis. Growth comes from chilled soups, free-from ranges and coeliac awareness, and faces cross-contact costs and fading diet interest.

How large will the Gluten-Free Soup Market be by 2036?

The market is projected to reach $3.20 billion by 2036, up from $1.70 billion in 2026. The increase of $1.50 billion reflects chilled soups, cartons and Asia Pacific demand.

What is the CAGR for the Gluten-Free Soup Market 2026 to 2036?

The market is forecast to grow at a 6.5% CAGR from 2026 to 2036. The bull case reaches 7.8% and the bear case 5.2%, depending on chilled adoption, diagnosis rates and retailer free-from space.

Which segment is growing fastest?

Chilled and Fresh Gluten-Free Soups is the fastest-growing segment at 9.1% CAGR, roughly 1.40 times the overall market rate. Shelf-Stable Gluten-Free Cartons and Pouches follows at 7.8% CAGR, led by clean-label convenience.

Who are the major companies in the Gluten-Free Soup Market?

Major companies include Campbell Company, General Mills, Amy's Kitchen, Hain Celestial and Unilever. Nestle, Baxters, Premier Foods, Dr. Schar and Massel also hold meaningful positions in specific regions.

Which country is growing fastest?

Australia is growing fastest at about 9.0% CAGR, because high coeliac awareness, strict labelling and retailer free-from ranges expand together. New Zealand and India follow through health interest and naturally gluten-free soups.

Report Segmentation Architecture

The full report scope spans multiple orthogonal segmentation dimensions, with cross-tabulated demand data provided for each dimension pair. Coverage extends further to regional breakdowns, trend trajectories, and the competitive detail needed to support segment-level decision-making.

By Primary Market Dimension

  • Chilled and Fresh Gluten-Free Soups
  • Shelf-Stable Cartons and Pouches
  • Canned Gluten-Free Soups
  • Instant Cups and Dry Mixes
  • Frozen Gluten-Free Soups

By End-Use Industry

  • Coeliac Households
  • Health-Focused Households
  • Restaurants and Foodservice
  • Institutional and Healthcare Catering

By Commercial Dimension

  • Supermarket and Hypermarket Sales
  • Natural and Specialty Food Stores
  • Online Retail and Subscription
  • Foodservice Distribution
  • Private Label Contract Manufacturing

By Region

  • North America
  • Western Europe
  • East Asia
  • South Asia and Pacific
  • Latin America
  • Middle East and Africa
  • Eastern Europe

Scope, Methodology, and Coverage

Every figure in this report is reproducible from documented input assumptions. The scope below maps the historical period, the forecast horizon, the segmentation dimensions, and the countries covered, alongside the underlying primary and qualitative methodology.
Historical Period
2020 to 2025
Forecast Period
2026 to 2036
Base Year
2025 (USD billions; MMA Primary Research Dataset, September 2026)
Market Definition
The market covers global sales of gluten-free soup, defined as ready-to-eat and dry soups labelled gluten-free under national limits such as 20 parts per million, in chilled and fresh soups, shelf-stable cartons and pouches, instant cups and dry mixes, canned soups and frozen soups, sold through retail, foodservice and online channels and valued at manufacturer sales revenue. It excludes soups that are gluten-free but not labelled or marketed as such, stocks and broths sold as cooking ingredients and restaurant-prepared soups.
Quantitative Units
USD billions (manufacturer sales revenue); thousand tonnes for volume references
Segmentation Dimensions
By Product Format; By End-Use Industry; By Commercial Dimension; By Region
Regions Covered
North America, Western Europe, East Asia, South Asia and Pacific, Latin America, Middle East and Africa, Eastern Europe
Countries Covered
United States, Canada, Mexico, United Kingdom, Ireland, Germany, Italy, Spain, France, Netherlands, Japan, China, South Korea, India, Australia, New Zealand, Singapore, Brazil, Argentina, Chile, United Arab Emirates, South Africa, Poland, Czechia, Hungary, and additional markets relevant to this sector
Key Companies Profiled
Campbell Company, General Mills, Amy's Kitchen, Hain Celestial, Unilever, Nestle, Kraft Heinz, Premier Foods, Baxters, Blount Fine Foods, Kettle Cuisine, Kettle & Fire, Dr. Schar, Bob's Red Mill, McCormick, Tabatchnick Fine Foods, Fody Foods, Massel, Ajinomoto, Nissin Foods
Quantitative Methodology
Primary survey, n=3,800 respondents, Q4 2025, six countries; demand-side model with trade association cross-validation
Qualitative Methodology
47 expert interviews, Q4 2025; applied to validate demand model assumptions, identify emerging dynamics, and assess competitive positioning
Report Format
PDF and XLSX data workbook (Word format preview document)
Publisher
Market Minds Advisory
Report Code
MMA-2026-AGR-316
Published
September 2026
Contact
sales@marketmindsadvisory.com | www.marketmindsadvisory.com

Purchase the full Gluten-Free Soup Market Report (2026 to 2036).

The full report delivers a detailed assessment of the global gluten-free soup market through 2036, covering product format, end-use, channel and regional forecasts, competitive benchmarking of leading soup majors, organic brands and chilled soup makers, and input cost analysis. It combines MMA primary research, including a six-country survey of 3,800 respondents and 47 expert interviews, with public statistical and company data. Analysts also model ingredient, packaging and testing scenarios. Clients receive segment margin ranges, supply maps and a case study on growth strategy. Buyer negotiation frameworks are also included.
Ten-year product format and end-use demand forecasts
Ingredient, packaging and testing cost tracking
Competitive benchmarking of leading gluten-free soup brands
Gluten-free labelling regulation tracker with alerts
Regional comparative analysis and forecasts included
Quarterly primary survey data update access

Built For The People Who Decide

From boardroom strategy to bench-side execution, this report is read cover-to-cover by leaders shaping the next decade of their industry, turning demand scenarios, market dynamics and valuation benchmarks into decisions.
CXOs/ Presidents/ VPs/ Managers
M&A and Corporate Development
Strategy Teams and R&D Heads
Procurement and Product Directors
Regulatory and Compliance Leaders
Investor Relations and Equity Analysts